Proof-of-Concept ETF Study Published in JAPMA
O’Brien Medical is pleased to announce the publication of our ETF proof-of-concept study in the world’s premier podiatry journal, JAPMA. This clinical trial evaluated the efficacy of the ETF at detecting diabetic peripheral neuropathy (DPN) compared to current standard neurological screening tests. The ETF was found to be more sensitive at detecting neuropathy compared to traditional methods. These findings further support the concept of implementing the ETF as a standardized method of identifying and tracking the progression of DPN.